clinical trial · NCT00868530
Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects
Pfizer·phase3·completed·n = 53
Hemophilia AXyntha
brief summary
This study will evaluate the safety and efficacy of on-demand treatment with Xyntha in Chinese hemophilia A subjects.
started
Sep 1, 2008
primary completion
Dec 1, 2009
completion
Dec 1, 2009
last updated
Jun 12, 2025
official title
An Evaluation Of The Safety And Efficacy Of On-Demand Treatment With Xyntha (B Domain Deleted Recombinant Factor VIII, Albumin Free) In Chinese Subjects With Hemophilia A
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol